127 related articles for article (PubMed ID: 2204331)
1. Positron emission tomography in Creutzfeldt-Jakob disease.
Holthoff VA; Sandmann J; Pawlik G; Schröder R; Heiss WD
Arch Neurol; 1990 Sep; 47(9):1035-8. PubMed ID: 2204331
[TBL] [Abstract][Full Text] [Related]
2. Positron emission tomography and histopathology in Creutzfeldt-Jakob disease.
Goldman S; Laird A; Flament-Durand J; Luxen A; Bidaut LM; Stanus E; Hildebrand J; Przedborski S
Neurology; 1993 Sep; 43(9):1828-30. PubMed ID: 8414042
[TBL] [Abstract][Full Text] [Related]
3. Multitracer study with positron emission tomography in Creutzfeldt-Jakob disease.
Engler H; Lundberg PO; Ekbom K; Nennesmo I; Nilsson A; Bergström M; Tsukada H; Hartvig P; Långström B
Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):85-95. PubMed ID: 12483414
[TBL] [Abstract][Full Text] [Related]
4. Regional cerebral glucose metabolism in autopsy-confirmed Creutzfeldt-Jakob disease.
Matochik JA; Molchan SE; Zametkin AJ; Warden DL; Sunderland T; Cohen RM
Acta Neurol Scand; 1995 Feb; 91(2):153-7. PubMed ID: 7785428
[TBL] [Abstract][Full Text] [Related]
5. Bitemporal hypometabolism in Creutzfeldt-Jakob disease measured by positron emission tomography with [18F]-2-fluorodeoxyglucose.
Friedland RP; Prusiner SB; Jagust WJ; Budinger TF; Davis RL
J Comput Assist Tomogr; 1984 Oct; 8(5):978-81. PubMed ID: 6381559
[TBL] [Abstract][Full Text] [Related]
6. [Brain glucose metabolism in a patient with Creutzfeldt-Jakob disease measured by positron emission tomography].
Shishido F; Uemura K; Inugami A; Tomura N; Higano S; Fujita H; Tabata K; Sasaki H; Murakami M; Kanno I
Kaku Igaku; 1990 Jun; 27(6):649-54. PubMed ID: 2214329
[TBL] [Abstract][Full Text] [Related]
7. Serial positron emission tomography with fludeoxyglucose F 18 in Creutzfeldt-Jakob disease.
Ogawa T; Inugami A; Fujita H; Hatazawa J; Shimosegawa E; Kanno I; Okudera T; Uemura K; Nagata K
AJNR Am J Neuroradiol; 1995 Apr; 16(4 Suppl):978-81. PubMed ID: 7611090
[TBL] [Abstract][Full Text] [Related]
8. Positron emission tomography with [(18)F]FDG in the diagnosis of Creutzfeldt-Jakob disease (CJD).
Henkel K; Zerr I; Hertel A; Gratz KF; Schröter A; Tschampa HJ; Bihl H; Büll U; Grünwald F; Drzezga A; Spitz J; Poser S
J Neurol; 2002 Jun; 249(6):699-705. PubMed ID: 12111302
[TBL] [Abstract][Full Text] [Related]
9. Cerebral hypermetabolism demonstrated by FDG PET in familial Creutzfeldt-Jakob disease.
Nagasaka T; Nagasaka K; Ohta E; Shindo K; Takiyama Y; Shiozawa Z; Miyazawa N; Yamasaki N; Mori N; Onda H; Shinohara T
Clin Nucl Med; 2011 Aug; 36(8):725-7. PubMed ID: 21716034
[TBL] [Abstract][Full Text] [Related]
10. Multitracer study in Heidenhain variant of Creutzfeldt-Jakob disease: mismatch pattern of cerebral hypometabolism and perfusion imaging.
Pichler R; Ciovica I; Rachinger J; Weiss S; Aichner FT
Neuro Endocrinol Lett; 2008 Feb; 29(1):67-8. PubMed ID: 18283251
[TBL] [Abstract][Full Text] [Related]
11. Positron emission tomographic (PET) studies in dementia.
Goto I; Taniwaki T; Hosokawa S; Otsuka M; Ichiya Y; Ichimiya A
J Neurol Sci; 1993 Jan; 114(1):1-6. PubMed ID: 8433091
[TBL] [Abstract][Full Text] [Related]
12. 18F-fluorodeoxyglucose-PET and 99mTc-bicisate-SPECT in Creutzfeldt-Jakob disease.
Grünwald F; Pohl C; Bender H; Hartmann A; Menzel C; Ruhlmann J; Keller E; Biersack HJ
Ann Nucl Med; 1996 Feb; 10(1):131-4. PubMed ID: 8814717
[TBL] [Abstract][Full Text] [Related]
13. Metabolic Changes Detected by 18F-FDG PET in the Preclinical Stage of Familial Creutzfeldt-Jakob Disease.
Lu H; Jing D; Chen Y; Cui C; Gao R; Wang L; Liang Z; Chen K; Wu L
J Alzheimers Dis; 2020; 77(4):1513-1521. PubMed ID: 32925055
[TBL] [Abstract][Full Text] [Related]
14. Brain 18F-FDG PET/CT findings in a case of genetic Creutzfeldt-Jakob disease due to V203I heterozygous mutation in the PRNP gene.
Cistaro A; Cassalia L; Ferrara C; Atzori C; Vai D; Quartuccio N; Fania P; Vaudano GP; Imperiale D
J Neurol; 2017 Jan; 264(1):170-173. PubMed ID: 27844164
[No Abstract] [Full Text] [Related]
15. 11C-PiB PET studies in typical sporadic Creutzfeldt-Jakob disease.
Villemagne VL; McLean CA; Reardon K; Boyd A; Lewis V; Klug G; Jones G; Baxendale D; Masters CL; Rowe CC; Collins SJ
J Neurol Neurosurg Psychiatry; 2009 Sep; 80(9):998-1001. PubMed ID: 19332421
[TBL] [Abstract][Full Text] [Related]
16. [When does the brain atrophy in Creutzfeldt-Jakob disease? (author's transl)].
Kawai M; Iwata M; Takatsu M; Toyokura Y; Nagashima K
Rinsho Shinkeigaku; 1981 Aug; 21(8):691-7. PubMed ID: 7035045
[TBL] [Abstract][Full Text] [Related]
17. Glucose metabolism in sporadic Creutzfeldt-Jakob disease: a statistical parametric mapping analysis of (18) F-FDG PET.
Kim EJ; Cho SS; Jeong BH; Kim YS; Seo SW; Na DL; Geschwind MD; Jeong Y
Eur J Neurol; 2012 Mar; 19(3):488-93. PubMed ID: 22050286
[TBL] [Abstract][Full Text] [Related]
18. Amyloid- and FDG-PET in sporadic Creutzfeldt-Jakob disease: Correlation with pathological prion protein in neuropathology.
Matías-Guiu JA; Guerrero-Márquez C; Cabrera-Martín MN; Gómez-Pinedo U; Romeral M; Mayo D; Porta-Etessam J; Moreno-Ramos T; Carreras JL; Matías-Guiu J
Prion; 2017 May; 11(3):205-213. PubMed ID: 28509609
[TBL] [Abstract][Full Text] [Related]
19. Comparison of diffusion-weighted MRI with 18F-fluorodeoxyglucose-positron emission tomography/CT and electroencephalography in sporadic Creutzfeldt-Jakob disease.
Xing XW; Zhang JT; Zhu F; Ma L; Yin DY; Jia WQ; Huang XS; Pu CQ; Lang SY; Yu SY
J Clin Neurosci; 2012 Oct; 19(10):1354-7. PubMed ID: 22795494
[TBL] [Abstract][Full Text] [Related]
20. Photo essay. MRI and positron emission tomography findings in Heidenhain variant Creutzfeldt-Jakob disease.
Prasad S; Lee EB; Woo JH; Alavi A; Galetta SL
J Neuroophthalmol; 2010 Sep; 30(3):260-2. PubMed ID: 20581692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
